Concepedia

Stephen Lockhart

SL

Statistics

Publications

43

Citations

25.4K

H-Index

27

Active since

1983

Affiliations

Pfizer (United States)(Current)

Pfizer (United Kingdom)

BioNTech (Germany)

SUNY Upstate Medical University

University of Maryland, Baltimore

Stephen Lockhart is an author at Pfizer (United States) specializing in medicine, vaccination, and immunology.

ORCID

Top concepts

Publications per year

1983–2024

43

Publications

43

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Fernando P. Polack, Stephen J. Thomas, Nicholas Kitchin et al. · New England Journal of Medicine · 2020 · 15.1K citations · Full text

Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates

Edward E. Walsh, Robert W. Frenck, Ann R. Falsey et al. · New England Journal of Medicine · 2020 · 2.7K citations · Full text

Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults

Mark J. Mulligan, Kirsten E. Lyke, Nicholas Kitchin et al. · Nature · 2020 · 1.6K citations · Full text

Efficacy of a Pneumococcal Conjugate Vaccine against Acute Otitis Media

Juhani Eskola, Terhi Kilpi, Arto A. Palmu et al. · New England Journal of Medicine · 2001 · 1.5K citations · Full text

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Michèle Tameris, Mark Hatherill, Bernard Landry et al. · The Lancet · 2013 · 1K citations · Full text

, , +10

1–5 of 43